Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel
Condition(s):Chronic Stable Plaque PsoriasisLast Updated:March 27, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Stable Plaque PsoriasisLast Updated:March 27, 2017Completed
Condition(s):Juvenile Idiopathic ArthritisLast Updated:September 4, 2014Completed
Condition(s):Spondylitis, Ankylosing; RecurrenceLast Updated:November 16, 2016Completed
Condition(s):Spondylitis, AnkylosingLast Updated:June 16, 2020Completed
Condition(s):Chronic Idiopathic UrticariaLast Updated:June 2, 2015Withdrawn
Condition(s):Rheumatoid Arthritis; Vascular InflammationLast Updated:February 7, 2017Terminated
Condition(s):Rheumatoid Arthritis; Psoriatic ArthritisLast Updated:September 4, 2018Completed
Condition(s):PsoriasisLast Updated:July 24, 2014Completed
Condition(s):Juvenile Idiopathic ArthritisLast Updated:February 1, 2011Unknown status
Condition(s):Ankylosing SpondylitisLast Updated:January 20, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.